Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D002648:Child; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D008198:Lymph Nodes / Q000473:pathology; D010614:Pharynx / Q000382:microbiology; D012409:Rubella / Q000276:immunology* / Q000473:pathology; D012411:Rubella Vaccine; D012412:Rubella virus / Q000276:immunology* / Q000302:isolation & purification; D012877:Skin Manifestations; D014611:Vaccination; D014765:Viral Vaccines
D000906:Antibodies; D012411:Rubella Vaccine; D014765:Viral Vaccines